Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Investors often wonder when the divisor resets after a stock split and what this means for index values. This intro clarifies the timing and practical implications for benchmarks.
22,047 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
GameStop outperforms other meme stocks in 2026, climbing as speculative bets and buyout chatter around Ryan Cohen fue...
Bitcoin surged to $71,000 as hyperliquid (hype) rockets double sparked momentum across the crypto market. Ethereum cl...
As mega-cap tech pours capital into AI, investors seek signs of durable returns. This piece analyzes which firms stan...
loandepot reports $108m loss for 2025, reflecting a tougher fourth quarter even as annual revenue and pull-through ma...
BitMEX co-founder Arthur Hayes signals he will not buy BTC now, citing a fragile liquidity backdrop and a need for Fe...
U.S. consumer prices rose modestly in February, keeping annual inflation at 2.4% with a 0.3% monthly gain. Analysts s...
The SEC and CFTC announced a formal partnership to harmonize crypto regulation and pursue new digital asset products....
A growing cohort of retirees is quietly collecting income from dividend-rich UK stocks, using low-cost funds that bun...
Navigator (NVGS) 2025 earnings paint a picture of a niche LNG carrier operator balancing utilization, rates and lever...
Vinod Khosla stepped in after Elon Musk pulled back from OpenAI’s pledge, funding a high-stakes bet that transformed ...
Retirees weigh claiming at 62 vs waiting to FRA in 2026 as Dave Ramsey’s controversial guidance remains hot. This pie...